M R Maniveni Foods IPO Review: Thin Margins, Thin Demand, and a Discount That Kept Widening

Quick Answer

M R Maniveni Foods IPO struggled from the very start, and the stock has continued to struggle since. The Chennai based dal (pulses) processor, known for its MR Gold Dhall brand, drew only 982 total applications, weak enough that one reviewer described the sentiment as poor, and the grey market premium stayed at zero throughout. The stock listed on 1 June 2026 at Rs 42.55, an 18.17% discount to the Rs 52 issue price, recovered only slightly to a high of Rs 44.66, and has since slid further to around Rs 37, roughly 29% below the issue price. A wafer-thin 2.87% profit margin, in a highly competitive, fragmented pulses processing segment, was flagged as concerning even before the issue closed.

M R Maniveni Foods IPO Key Details at a Glance

What Does M R Maniveni Foods Ltd Do?

M R Maniveni Foods, incorporated in June 2010 and based in Madhavaram, Chennai, mills, processes and supplies pulses under the MR Gold Dhall brand, with its core focus on urad dal and toor dal. The company also trades in a broader range including moong dal, kabuli channa, green gram dal, coriander seeds, rice and chillies, serving a B2B customer base of large-format retailers, wholesalers and e-commerce platforms.

The operational setup. The company runs two dedicated milling facilities, a fully automated unit installed in 2022 for urad dal, and a semi-automated, semi-manual unit for toor dal. This dual approach gives it some scalability through automation while retaining flexibility for specialised demand. You can follow its live price and post listing updates on the IPO GMP Live homepage.

The scale. Despite processing over Rs 200 crore of revenue in FY25, the company runs with just 16 employees as of April 2026, a genuinely lean operation even by SME standards, reflecting the low-value-add, high-volume nature of pulses milling and trading. It holds FSSAI, ISO-22000 and ZED-Bronze certifications under the MSME scheme.

How Strong Are M R Maniveni Foods Financials?

Revenue has grown substantially over three years, though the pace has since slowed. Revenue rose from Rs 119.61 crore in FY23 to Rs 203.52 crore in FY25, about 70% growth over two years. However, the nine months to December 2025 brought in Rs 116.19 crore, which annualises to roughly Rs 155 crore, a clear deceleration from the FY25 pace rather than a continuation of it.

Profit growth has been steadier but on a very thin base. Net profit rose from Rs 1.56 crore in FY23 to Rs 4.13 crore in FY25, and the nine-month FY26 figure of Rs 3.34 crore annualises to around Rs 4.5 crore, modest continued growth but well below the acceleration the FY24 to FY25 jump might have suggested.

The margin structure is the central concern, and it was flagged before listing. A PAT margin of just 2.87% and EBITDA margin of 5.74% are wafer-thin even by the standards of commodity food processing, and the company carries a debt-to-equity ratio of 1.02 on top of that. One reviewer covering the listing specifically noted this combination, thin margins and real leverage, sat awkwardly against what was described as aggressive pricing for a pulses processing company operating in a highly competitive, fragmented segment where differentiation and pricing power are both hard to come by.

Why Did the IPO and the Stock Both Struggle?

Several factors compounded each other here:

• Demand was weak from the outset, and the numbers confirm it. Only 982 total applications came in for the entire issue, an unusually low figure that one reviewer explicitly called out as reflecting poor investor sentiment, and the QIB portion barely scraped through at exactly 1.00 times.
• The GMP told an accurate story for once. With zero or unavailable grey market premium throughout the subscription window, the market was signalling a weak or flat listing well in advance, and the actual 18% discount debut matched that caution rather than surprising anyone paying attention.
• The revenue deceleration undercut the growth narrative. A company priced partly on its 70% two-year revenue growth then reported nine-month FY26 numbers annualising to a slower pace, removing one of the few positives that might have supported the stock post-listing.
• Thin margins in a commodity segment offer little room for error. With a 2.87% profit margin and real debt on the balance sheet, any rise in raw pulses costs, freight, or competitive pricing pressure quickly erodes what little cushion the business has, a risk that becomes more visible to the market with every quarter that passes.

Should You Buy M R Maniveni Foods Shares Now?

The stock trades around Rs 37 against a Rs 52 issue price. The honest read by investor type:

• Conservative investors: Stay away. A wafer-thin margin business with real leverage, in a fragmented commodity segment with essentially no pricing power, offers little safety at any price, and the market has already voted with a weak listing and a further decline since.
• Moderate investors: There is no urgency to step in. The recent revenue deceleration undercuts the main positive in the story, and until the company demonstrates it can defend or expand its thin margins through at least a couple of full quarterly cycles, this is one to watch rather than own.
• Aggressive investors: Even as a contrarian bet, the combination of decelerating growth, thin margins and real debt makes this a difficult case to build conviction around. Any position here should be treated as a small, speculative watch rather than a meaningful allocation.

Honest take. M R Maniveni Foods is a case where nearly every available signal, thin subscription, zero GMP, a wafer-thin margin structure, and real leverage, pointed the same direction before listing, and the market has simply continued to confirm those concerns since. The pulses processing business itself is a real, functioning operation with FSSAI and ISO certifications and genuine B2B relationships, but commodity food processing at a 2.87% margin leaves almost no room to absorb the kind of setback that any competitive or cost pressure could bring, and the recent revenue slowdown does nothing to ease that concern.

Where Did the IPO Money Go?

This was a 100% fresh issue of Rs 27.04 crore, with no offer for sale. The two largest allocations fund capital expenditure, roughly Rs 10.44 crore for new plant and machinery and Rs 8.85 crore for constructing a new factory, both aimed at expanding processing capacity. The balance covers general corporate purposes and issue expenses. The capex-directed use of funds is sensible for a scaling processor, but expanding capacity does little to address the underlying thin-margin, highly competitive nature of the business itself.

Contact Details

• Company: M R Maniveni Foods Ltd.
• Location: S.No.220/3A-3B, Madhavaram-Redhills High Road, Madhavaram, Chennai, Tamil Nadu
• Business: Milling, processing and B2B supply of pulses under the MR Gold Dhall brand, primarily urad dal and toor dal, with trading in other grains and spices
• Promoters: K R Manikandan (Managing Director), M Chandra, K Selvam
• Registrar: Bigshare Services Pvt. Ltd.
• Lead Manager: Capital Square Advisors Pvt. Ltd.
• Market Maker: CapitalSquare Financial Services Pvt. Ltd.
• Listing: BSE SME

This page is not investment advice. GMP is indicative only and unofficial. Please consult a SEBI registered financial advisor before investing.